drug

FDA scientist sentenced to five years in prison for insider trading on drug approval knowledge

Friday, March 09, 2012 by: Jonathan Benson, staff writer
Tags: FDA, insider trading, drug approvals

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Russia taking McDonald's to court, threatens countrywide shutdown
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Why does the CDC own a patent on Ebola 'invention?'
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Oregon man serving prison sentence for collecting rainwater on his own property
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Diet soda, aspartame linked to premature deaths in women
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Right to farm being stripped from Americans: Michigan to criminalize small family farms with chickens, goats, honey bees and more
Monsanto's seed imperialism halted in Canada thanks to massive protests
Delicious
(NaturalNews) A drug evaluator at the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research for more than a decade, Cheng Yi Liang, 58, has been sentenced to five years in prison and three years of supervised release for using non-public FDA data to conduct illegal insider trading.

According to reports, Liang generated more than $3.7 million, which he is now being required to forfeit, by accessing confidential documents about new or experimental drugs to which he had access. He then used this information to time precisely when he would make the most profit from their stocks, as well as when to pull out of them to avoid losses.

"Cheng Yi Liang bought and sold stocks based on non-public information, and he tried to conceal his crimes by using the names of friends and relatives," wrote U.S. Attorney Rod J. Rosenstein to Bloomberg in an email statement. "Mr. Liang violated his duty of loyalty to the FDA and profited from inside information."

Liang's investing sprees allegedly took place between July 2006 and March 2011, during which time he paid close attention to when new drug announcements were set to be made, and made his investments appropriately. The lawsuit filed against Liang by the U.S. government alleges that he made an average profit of $135,015 per announcement.

Prior to the official January 21, 2011, announcement that Clinical Data Inc.'s Viibryd drug for depression had been approved by the FDA, for instance, Liang reportedly made $380,000 by purchasing stocks before this information was made public. And in the case of Vanda Pharmaceuticals Inc.'s Fanapt drug for schizophrenia, Liang generated more than $1 million.

Meanwhile, many members of the U.S. Congress routinely engage in insider trader schemes, and virtually none of them are ever questioned about this practice, let alone arrested and jailed for it. House Minority Leader Nancy Pelosi (D-Ca.), Speaker of the House John Boehner (R-Oh.), and Rep. Spencer Bachus (R-Ala.), to name just a few, were all identified in a 2011 60 Minutes segment as being among the many Congressional leaders involved in insider trader schemes (http://articles.businessinsider.com).

"This is a venture opportunity," said Peter Schweizer, a fellow at the Hoover Institution, during the 60 Minutes report about rampant insider trading in Capitol Hill. "This is an opportunity to leverage your position in public service and use that position to enrich yourself, your friends, and your family."

Sources for this article include:

http://www.reuters.com

http://www.bloomberg.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.